Dabur India Q4FY26: Sales up 5%, profit 7%

Brokerages stay positive, but execution remains a key worry

Most brokerages retained their ratings and price targets on Dabur India after the company reported Q4FY26 results that were broadly in line with estimates. Analysts highlighted improving growth in the India business as the main support for the quarter’s performance. At the same time, they stayed cautious on Dabur’s ability to sustain the momentum, pointing to a weak execution track record over the years.

Motilal Oswal Financial Services said revenue growth improved to 5% in FY26 after 1.3% growth in FY25. The brokerage also pointed to a guidance change from the company, with Dabur revising its India business revenue outlook from “high single-digit” to “low double-digit”, expecting a mix of volume and pricing growth in FY27. But it added that the historical execution weakness remains a concern even as the broader India consumption backdrop is seen as supportive.

Q4FY26 headline numbers: profit rises, but sequential drop stands out

Dabur reported consolidated net profit of ₹369 crore in the March quarter, compared with ₹320 crore in the year-ago period, a 15% year-on-year increase. While the year-on-year comparison was steady, sequential performance was weaker. Profit after tax fell 34% quarter-on-quarter compared with ₹560 crore in Q3FY26.

The topline also declined 15% quarter-on-quarter versus ₹3,559 crore in Q3FY26, as per the figures referenced in the same set of results commentary. The company’s board also fixed the date of its fifty-first annual general meeting for Thursday, August 6, 2026.

India business drives Q4 growth; volumes improve

Analysts said Dabur’s Q4 results were driven by healthier growth in the domestic business. Consolidated revenue increased around 7% year-on-year in Q4FY26, led by India business revenue growth of 10%. Separately, Dabur said in its filing that its India FMCG business posted 9.5% growth during the quarter.

Volume trends also improved. India business volume grew 6% in Q4FY26, up from 3% in Q3FY26. Rural markets continued to outperform urban consumption by about 350 basis points, extending a trend that has been important for staples-heavy FMCG portfolios.

Segment performance: HPC leads, healthcare steady, F&B modest

The Home and Personal Care (HPC) vertical remained the key growth engine, with revenue growth of 17% year-on-year in Q4FY26. The healthcare portfolio grew around 4%, while the food and beverages (F&B) segment improved by 3% year-on-year.

Management commentary indicated that demand recovery in HPC during the second half of the fiscal year is expected to continue. This matters because HPC is typically a higher-frequency, brand-led part of the portfolio and tends to reflect changes in consumer spending faster than seasonal categories.

Category-level growth and market share commentary

Dabur reported broad-based growth across key categories in Q4FY26. Hair Care rose 27%, while Hair Oils grew 28%. Home Care grew over 24%, Digestives rose around 15%, and Skin and Salon as well as the Badshah portfolio expanded 12% each. Toothpaste and the OTC and Ethicals businesses posted over 7% growth.

The company said strong brand positioning helped it manage inflationary pressures, with gains across segments including Honey, Health Juices, Oral Care and Foods. Dabur also said it recorded market share gains across 95% of its portfolio, led by Hair Oils, Digestives, Fruit Nectars and Air Fresheners.

International business: modest growth amid Middle East pressure

Dabur’s international business grew 2.5% during the quarter, despite challenges in the Middle East. The company said the performance was supported by strong growth in Sub-Saharan Africa, Bangladesh, UK and EU, and Namaste US operations.

Dabur India Limited Global Chief Executive Officer Mohit Malhotra said the company navigated a tougher operating environment amid heightened geopolitical tensions in the Middle East. The company linked these conditions to inflation, higher freight costs, and weaker consumer demand in select markets.

Peer comparison: Nomura flags a gap in volume growth

Nomura noted that Dabur’s India volume growth of 6% in Q4FY26 lagged some peers, even on a low base. The brokerage compared this with volume growth of 9% for Marico and 8% for Godrej Consumer Products. The comparison is relevant because it frames Dabur’s recovery as improving, but not yet leading, within the large-cap FMCG set.

Full-year FY26 results and recent operating context

For FY2025-26, Dabur reported revenue growth of 5% to ₹13,193 crore, while net profit for the year rose 7.4% to ₹1,869 crore. These numbers align with the view that FY26 represented a step up from FY25’s low growth, but still not a sharp acceleration.

The company’s FY26 trajectory included a soft Q1FY26, when unseasonal rains affected summer-linked beverages and glucose. Q2FY26 revenue growth was described as being impacted by a Goods and Services Tax (GST) rate cut in September 2025, which triggered destocking and deferred primary sales. By Q3FY26, Dabur reported normalisation, with consolidated revenue growth of 6.1% supported by 6% India FMCG growth on 3% volume growth.

Key numbers at a glance

Why the quarter matters for investors

For investors tracking Dabur, the quarter brings two opposing signals into focus. On one hand, the India business improved on both value and volume, and HPC led segment growth with signs of a demand recovery in H2FY26. On the other hand, brokerages have continued to underline execution risk, especially when relative growth lags peers, as flagged by Nomura’s comparison.

The updated guidance stance also adds context. Dabur’s move from high single-digit to low double-digit India business revenue guidance for FY27 indicates management is positioning for stronger growth through both pricing and volumes. But brokerages such as Motilal Oswal have indicated that guidance will need to be backed by consistent delivery, given the company’s historical execution concerns.

Conclusion

Dabur India’s Q4FY26 results showed a year-on-year improvement supported by domestic growth, rising volumes, and a strong showing in HPC, while international markets faced pressure in parts of the Middle East. Brokerages largely retained ratings and targets, but commentary remained cautious on execution and relative performance versus peers. The next key checkpoint for investors will be whether the company can sustain the H2FY26 momentum and deliver on its FY27 India business growth guidance.